George C. Griffith, M.D., F.A.C.P.; George Nichols Jr., M.D.; John D. Asher, M.D.
This content is PDF only. Please click on the PDF icon to access.
Treatment of 117 men with up to 100 mg of heparin daily for 2 to 15 years in the prophylaxis of arteriosclerotic and thromboembolic disease was without apparent skeletal complications. When dosage was raised to 200 to 300 mg/day, six of ten men so treated developed marked osteoporosis by X ray, and multiple vertebral compression fractures within 2 years. Serum calcium, phosphorus, acid, and alkaline phosphatase were normal in all patients affected, as were rates of calcium, phosphorus, hydroxyproline excretion, and renal tubular resorption of phosphorus when tested. Parathyroid response to infusions of calcium and ethylenediamine-tetra-acetic acid was examined in
Learn more about subscription options.
Register Now for a free account.
Griffith GC, Nichols G, Asher JD. Heparin Osteoporosis.. Ann Intern Med. 1965;63:921–922. doi: 10.7326/0003-4819-63-5-921_3
Download citation file:
Published: Ann Intern Med. 1965;63(5):921-922.
Endocrine and Metabolism, Metabolic Bone Disorders.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only